238 related articles for article (PubMed ID: 10099040)
1. Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine.
Radwanski E; Nomeir A; Cutler D; Affrime M; Lin CC
Am J Ther; 1998 Mar; 5(2):67-72. PubMed ID: 10099040
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
Stass H; Böttcher MF; Ochmann K
Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
[TBL] [Abstract][Full Text] [Related]
3. High dose of antacid (Mylanta II) reduces bioavailability of ranitidine.
Mihaly GW; Marino AT; Webster LK; Jones DB; Louis WJ; Smallwood RA
Br Med J (Clin Res Ed); 1982 Oct; 285(6347):998-9. PubMed ID: 6289961
[TBL] [Abstract][Full Text] [Related]
4. Oral bioavailability of nizatidine and ranitidine concurrently administered with antacid.
Desager JP; Harvengt C
J Int Med Res; 1989; 17(1):62-7. PubMed ID: 2565267
[TBL] [Abstract][Full Text] [Related]
5. Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil.
Blouin RA; Kneer J; Ambros RJ; Stoeckel K
Antimicrob Agents Chemother; 1990 Sep; 34(9):1744-8. PubMed ID: 1981000
[TBL] [Abstract][Full Text] [Related]
6. Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids.
Snell P; Oo C; Dorr A; Barrett J
Br J Clin Pharmacol; 2002 Oct; 54(4):372-7. PubMed ID: 12392584
[TBL] [Abstract][Full Text] [Related]
7. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.
Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z
Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201
[TBL] [Abstract][Full Text] [Related]
8. The effect of antacid and ranitidine on droxicam pharmacokinetics.
Bartlett A; Costa A; Martínez L; Roser R; Sagarra R; Sánchez J
J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550
[TBL] [Abstract][Full Text] [Related]
9. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
[TBL] [Abstract][Full Text] [Related]
10. Interaction of meloxicam with cimetidine, Maalox, or aspirin.
Busch U; Heinzel G; Narjes H; Nehmiz G
J Clin Pharmacol; 1996 Jan; 36(1):79-84. PubMed ID: 8932547
[TBL] [Abstract][Full Text] [Related]
11. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin.
Nix DE; Watson WA; Lener ME; Frost RW; Krol G; Goldstein H; Lettieri J; Schentag JJ
Clin Pharmacol Ther; 1989 Dec; 46(6):700-5. PubMed ID: 2598571
[TBL] [Abstract][Full Text] [Related]
12. Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects.
Kubitza D; Becka M; Zuehlsdorf M; Mueck W
J Clin Pharmacol; 2006 May; 46(5):549-58. PubMed ID: 16638738
[TBL] [Abstract][Full Text] [Related]
13. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
[TBL] [Abstract][Full Text] [Related]
14. Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers.
Yasuda S; Higashi S; Murakami M; Tomono Y; Kawaguchi M
Int J Clin Pharmacol Ther; 1999 May; 37(5):249-53. PubMed ID: 10363624
[TBL] [Abstract][Full Text] [Related]
15. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.
Krishna R; East L; Larson P; Valiathan C; Butterfield K; Teng Y; Hernandez-Illas M
J Pharm Pharmacol; 2016 Nov; 68(11):1359-1365. PubMed ID: 27671833
[TBL] [Abstract][Full Text] [Related]
16. Influence of an antacid containing aluminum and magnesium on the pharmacokinetics of cefixime.
Healy DP; Sahai JV; Sterling LP; Racht EM
Antimicrob Agents Chemother; 1989 Nov; 33(11):1994-7. PubMed ID: 2610509
[TBL] [Abstract][Full Text] [Related]
17. Reduced oral itraconazole bioavailability by antacid suspension.
Lohitnavy M; Lohitnavy O; Thangkeattiyanon O; Srichai W
J Clin Pharm Ther; 2005 Jun; 30(3):201-6. PubMed ID: 15896236
[TBL] [Abstract][Full Text] [Related]
18. The effect of an antacid and food on the absorption of cimetidine and ranitidine.
Desmond PV; Harman PJ; Gannoulis N; Kamm M; Mashford ML
J Pharm Pharmacol; 1990 May; 42(5):352-4. PubMed ID: 1976784
[TBL] [Abstract][Full Text] [Related]
19. Effect of an Antacid (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone) or a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Adult Subjects.
Patel G; Gupta VK; Gasink L; Bajraktari F; Lei Y; Jain A; Srivastava P; Talley AK
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0149522. PubMed ID: 36943038
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib.
Scott G; Vinluan Reynolds C; Milosavljev S; Langholff W; Shenouda M; Rordorf C
Clin Pharmacokinet; 2004; 43(5):341-8. PubMed ID: 15080766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
